Description

ASCORIL SF SYRUP 100 ML

Indications

Ascoril SF Syrup is a combination medication primarily indicated for the treatment of respiratory conditions characterized by excessive mucus production and bronchospasm. It is commonly prescribed for patients suffering from conditions such as chronic obstructive pulmonary disease (COPD), asthma, and bronchitis. The syrup helps alleviate symptoms such as cough, wheezing, and difficulty in breathing by promoting mucus clearance and relaxing the airways.

Mechanism of Action

Ascoril SF Syrup contains a blend of active ingredients, including bromhexine, guaifenesin, and salbutamol. Each component plays a distinct role in the therapeutic effect of the syrup. Bromhexine is a mucolytic agent that works by breaking down mucus, making it less viscous and easier to expel. Guaifenesin acts as an expectorant, facilitating the clearance of mucus from the airways. Salbutamol is a bronchodilator that relaxes the muscles of the airways, leading to dilation and improved airflow. Together, these ingredients provide a comprehensive approach to managing respiratory symptoms.

Pharmacological Properties

The pharmacological properties of Ascoril SF Syrup are attributed to its active ingredients. Bromhexine has a rapid onset of action and is well-absorbed in the gastrointestinal tract, with a half-life of approximately 8 to 12 hours. Guaifenesin enhances mucociliary clearance and has a relatively short half-life, necessitating multiple doses for sustained effect. Salbutamol, a selective beta-2 adrenergic agonist, acts quickly to relieve bronchospasm, with effects typically observed within minutes and lasting for several hours. The combination of these agents results in improved respiratory function and symptom relief in patients with obstructive airway diseases.

Contraindications

Ascoril SF Syrup is contraindicated in patients with a known hypersensitivity to any of its components. It should not be used in individuals with a history of severe asthma attacks or those experiencing acute bronchospasm. Patients with specific medical conditions, such as severe hypertension, tachyarrhythmias, or hyperthyroidism, should also avoid this medication unless under strict medical supervision. Additionally, it is not recommended for use in children under the age of two without medical advice.

Side Effects

While Ascoril SF Syrup is generally well-tolerated, some patients may experience side effects. Common side effects include nausea, vomiting, diarrhea, and gastrointestinal discomfort. In some cases, patients may report dizziness, tremors, or palpitations, particularly due to the salbutamol component. Allergic reactions, although rare, may occur and can manifest as rashes, itching, or swelling. It is essential for patients to report any unusual or severe side effects to their healthcare provider promptly.

Dosage and Administration

The recommended dosage of Ascoril SF Syrup varies based on the patient’s age and the severity of the condition. For adults and children over the age of 12, the typical dosage is 10 ml three times a day. For children aged 6 to 12 years, the dosage is usually 5 ml three times a day, and for children aged 2 to 6 years, it is 2.5 ml three times a day. The syrup should be taken after meals to minimize gastrointestinal irritation. It is crucial to follow the prescribing physician’s instructions and not exceed the recommended dosage to avoid potential toxicity.

Interactions

Ascoril SF Syrup may interact with other medications, potentially altering its effectiveness or increasing the risk of side effects. Patients taking other bronchodilators, diuretics, or monoamine oxidase inhibitors (MAOIs) should inform their healthcare provider, as these combinations may lead to additive effects or increased cardiovascular risks. Additionally, the syrup may enhance the effects of sedatives and tranquilizers, leading to increased drowsiness. A thorough review of the patient’s medication history is essential to prevent potential drug interactions.

Precautions

Patients should exercise caution when using Ascoril SF Syrup, especially those with pre-existing health conditions such as cardiovascular disorders, diabetes, or seizure disorders. It is important to monitor for any exacerbation of symptoms or adverse effects, particularly in elderly patients or those with comorbidities. Pregnant or breastfeeding women should consult their healthcare provider before using this medication, as safety during these periods has not been fully established. Patients should also be advised to avoid alcohol consumption while taking this syrup, as it may exacerbate side effects.

Clinical Studies

Clinical studies have evaluated the efficacy and safety of Ascoril SF Syrup in various populations. Research has demonstrated significant improvements in respiratory function and symptom relief in patients with COPD and asthma when using this medication. A randomized controlled trial published in a peer-reviewed journal indicated that patients receiving Ascoril SF experienced a marked reduction in cough frequency and an improvement in quality of life compared to those receiving a placebo. Further studies have supported the combination of bromhexine, guaifenesin, and salbutamol as an effective treatment strategy for managing chronic respiratory conditions.

Conclusion

Ascoril SF Syrup is a valuable therapeutic option for patients suffering from respiratory disorders characterized by excessive mucus production and bronchospasm. Its combination of mucolytic, expectorant, and bronchodilator properties provides comprehensive symptom relief. However, it is essential for patients to use this medication responsibly, adhering to prescribed dosages and monitoring for any adverse effects. Consultation with a healthcare provider is crucial to ensure safe and effective use, particularly in patients with underlying health conditions or those taking other medications.